152 related articles for article (PubMed ID: 24013228)
21. Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1.
Tong X; Mirzoeva S; Veliceasa D; Bridgeman BB; Fitchev P; Cornwell ML; Crawford SE; Pelling JC; Volpert OV
Oncotarget; 2014 Nov; 5(22):11413-27. PubMed ID: 25526033
[TBL] [Abstract][Full Text] [Related]
22. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
[TBL] [Abstract][Full Text] [Related]
23. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
24. In vivo upregulation of CD95 and CD95L causes synergistic inhibition of angiogenesis by TSP1 peptide and metronomic doxorubicin treatment.
Quesada AJ; Nelius T; Yap R; Zaichuk TA; Alfranca A; Filleur S; Volpert OV; Redondo JM
Cell Death Differ; 2005 Jun; 12(6):649-58. PubMed ID: 15818399
[TBL] [Abstract][Full Text] [Related]
25. Thrombospondin-1 triggers cell migration and development of advanced prostate tumors.
Firlej V; Mathieu JR; Gilbert C; Lemonnier L; Nakhlé J; Gallou-Kabani C; Guarmit B; Morin A; Prevarskaya N; Delongchamps NB; Cabon F
Cancer Res; 2011 Dec; 71(24):7649-58. PubMed ID: 22037878
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin.
Gu Y; Scheuer C; Feng D; Menger MD; Laschke MW
Anticancer Drugs; 2013 Sep; 24(8):781-91. PubMed ID: 23744558
[TBL] [Abstract][Full Text] [Related]
27. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.
Beecken WD; Engl T; Jonas D; Blaheta RA
Int J Mol Med; 2009 Feb; 23(2):261-6. PubMed ID: 19148551
[TBL] [Abstract][Full Text] [Related]
28. CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis.
Gao L; Chen K; Gao Q; Wang X; Sun J; Yang YG
Oncotarget; 2017 Apr; 8(14):22406-22413. PubMed ID: 27283989
[TBL] [Abstract][Full Text] [Related]
29. Androgen and fibroblast growth factor 8 (FGF8) downregulation of thrombospondin 1 (TSP1) in mouse breast cancer cells.
Mattila MM; Tarkkonen KM; Seppänen JA; Ruohola JK; Valve EM; Härkönen PL
Mol Cell Endocrinol; 2006 Jul; 253(1-2):36-43. PubMed ID: 16723184
[TBL] [Abstract][Full Text] [Related]
30. Therapies using anti-angiogenic peptide mimetics of thrombospondin-1.
Henkin J; Volpert OV
Expert Opin Ther Targets; 2011 Dec; 15(12):1369-86. PubMed ID: 22136063
[TBL] [Abstract][Full Text] [Related]
31. Dynamic expression of bone morphogenetic protein 4 in reproductive organs of female mice.
Tanwar PS; McFarlane JR
Reproduction; 2011 Oct; 142(4):573-9. PubMed ID: 21810858
[TBL] [Abstract][Full Text] [Related]
32. Interruption of the HGF paracrine loop by NK4, an HGF antagonist, reduces VEGF expression of CT26 cells.
Kubota T; Matsumura A; Taiyoh H; Izumiya Y; Fujiwara H; Okamoto K; Ichikawa D; Shiozaki A; Komatsu S; Nakanishi M; Kuriu Y; Murayama Y; Ikoma H; Ochiai T; Nakamura T; Matsumoto K; Nakamura T; Otsuji E
Oncol Rep; 2013 Aug; 30(2):567-72. PubMed ID: 23722408
[TBL] [Abstract][Full Text] [Related]
33. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
[TBL] [Abstract][Full Text] [Related]
34. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors.
Stoeltzing O; Ahmad SA; Liu W; McCarty MF; Wey JS; Parikh AA; Fan F; Reinmuth N; Kawaguchi M; Bucana CD; Ellis LM
Cancer Res; 2003 Jun; 63(12):3370-7. PubMed ID: 12810673
[TBL] [Abstract][Full Text] [Related]
35. A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growth.
Farnsworth RH; Karnezis T; Shayan R; Matsumoto M; Nowell CJ; Achen MG; Stacker SA
Cancer Res; 2011 Oct; 71(20):6547-57. PubMed ID: 21868759
[TBL] [Abstract][Full Text] [Related]
36. Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner.
Chen P; Huang Y; Bong R; Ding Y; Song N; Wang X; Song X; Luo Y
Clin Cancer Res; 2011 Dec; 17(23):7230-9. PubMed ID: 21994414
[TBL] [Abstract][Full Text] [Related]
37. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway.
Lorenzon E; Colladel R; Andreuzzi E; Marastoni S; Todaro F; Schiappacassi M; Ligresti G; Colombatti A; Mongiat M
Oncogene; 2012 Jun; 31(26):3136-47. PubMed ID: 22020326
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer.
Cao C; Albert JM; Geng L; Ivy PS; Sandler A; Johnson DH; Lu B
Cancer Res; 2006 Dec; 66(23):11409-15. PubMed ID: 17145887
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of angiogenesis and tumorigenesis, and induction of dormancy by p53 in a p53-null thyroid carcinoma cell line in vivo.
Nagayama Y; Shigematsu K; Namba H; Zeki K; Yamashita S; Niwa M
Anticancer Res; 2000; 20(4):2723-8. PubMed ID: 10953350
[TBL] [Abstract][Full Text] [Related]
40. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
